Get started
Author

Esther Kellenberger

Observed names: E Kellenberger, E. Kellenberger, Kellenberger, E, Kellenberger, E., Kellenberger, Esther
Observed institutions: Trudeau Institute, Centre National de la Recherche Scientifique, Université Libre de Bruxelles, State University of New York, Inserm, Institut de génétique et de biologie moléculaire et cellulaire, Institut de Science et d'Ingénierie Supramoléculaires, European Molecular Biology Laboratory, European Molecular Biology Laboratory, European Molecular Biology Laboratory, Laboratoire d'Innovation Thérapeutique, Centre de Biophysique Moléculaire, European Molecular Biology Laboratory, École Supérieure de Biotechnologie de Strasbourg, Biotechnologie et Signalisation Cellulaire, European Molecular Biology Laboratory, Université de Strasbourg
ORCID: 0000-0002-9320-4840
Observed ORCID: 0000-0002-9320-4840
OpenAlex ID: A5005741666
Comparative evaluation of eight docking tools for docking and virtual screening accuracy
2004 · Esther Kellenberger, Jordi Rodrigo, et al. · Proteins Structure Function and Bioinformatics · 575
sc-PDB: a 3D-database of ligandable binding sites—10 years on
2014 · Jérémy Desaphy, Guillaume Bret, et al. · Nucleic Acids Research · 299
PDF
A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors
2005 · Jean‐Sebastien Surgand, Jordi Rodrigo, et al. · Proteins Structure Function and Bioinformatics · 220
sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank
2006 · Esther Kellenberger, Pascal Muller, et al. · Journal of Chemical Information and Modeling · 198
Comparison and Druggability Prediction of Protein–Ligand Binding Sites from Pharmacophore-Annotated Cavity Shapes
2012 · Jérémy Desaphy, Karima Azdimousa, et al. · Journal of Chemical Information and Modeling · 155
Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
2011 · Javier Garcia-Perez, Patricia Rueda, et al. · Journal of Biological Chemistry · 117
Identification of Nonpeptide CCR5 Receptor Agonists by Structure-based Virtual Screening
2007 · Esther Kellenberger, Jean-Yves Springael, et al. · Journal of Medicinal Chemistry · 110
A simple and fuzzy method to align and compare druggable ligand‐binding sites
2008 · Claire Schalon, Jean‐Sébastien Surgand, et al. · Proteins Structure Function and Bioinformatics · 108
Recovering the true targets of specific ligands by virtual screening of the protein data bank
2004 · Nicodéme Paul, Esther Kellenberger, et al. · Proteins Structure Function and Bioinformatics · 108
sc-PDB: a database for identifying variations and multiplicity of ‘druggable’ binding sites in proteins
2011 · Jamel Meslamani, Didier Rognan, et al. · Bioinformatics · 107
Flavonoids as inhibitors of human CD38
2011 · Esther Kellenberger, Isabelle Kuhn, et al. · Bioorganic & Medicinal Chemistry Letters · 104
Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
2008 · Muriel Hachet-Haas, Karl Balabanian, et al. · Journal of Biological Chemistry · 96
New Insights into the Mechanisms whereby Low Molecular Weight CCR5 Ligands Inhibit HIV-1 Infection
2010 · Javier Garcia-Perez, Patricia Rueda, et al. · Journal of Biological Chemistry · 87
PDF
How to Measure the Similarity Between Protein Ligand-Binding Sites?
2008 · Esther Kellenberger, Claire Schalon, et al. · Current Computer - Aided Drug Design · 76
Dual Function for U2AF 35 in AG-Dependent Pre-mRNA Splicing
2001 · Sabine Guth, Thomas ∅. Tange, et al. · Molecular and Cellular Biology · 75
Similar interactions of natural products with biosynthetic enzymes and therapeutic targets could explain why nature produces such a large proportion of existing drugs
2011 · Esther Kellenberger, Andreas Hofmann, et al. · Natural Product Reports · 73
PDF
Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways
2025 · David Aranda-García, Tomasz Maciej Stepniewski, et al. · Nature Communications · 70
A bright future for fragment-based drug discovery: what does it hold?
2019 · Célien Jacquemard, Esther Kellenberger · Expert Opinion on Drug Discovery · 67
PDF
Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems
2008 · Esther Kellenberger, Nicolas Foata, et al. · Journal of Chemical Information and Modeling · 65
Structural Insights into the Molecular Basis of the Ligand Promiscuity
2012 · Noé Sturm, Jérémy Desaphy, et al. · Journal of Chemical Information and Modeling · 63
Selective Fluorescent Nonpeptidic Antagonists For Vasopressin V2GPCR: Application To Ligand Screening and Oligomerization Assays.
2012 · Stéphanie Loison, Martin Cottet, et al. · Journal of Medicinal Chemistry · 55
CCR5 adopts three homodimeric conformations that control cell surface delivery
2018 · Jun Jin, Fanny Momboisse, et al. · Science Signaling · 52
Production of Calcium-Mobilizing Metabolites by a Novel Member of the ADP-Ribosyl Cyclase Family Expressed inSchistosoma mansoni,
2005 · Stephen P. Goodrich, Hélène Muller-Steffner, et al. · Biochemistry · 47
Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD+ catabolizing enzyme
2010 · Isabelle Kuhn, Esther Kellenberger, et al. · Bioorganic & Medicinal Chemistry · 44
Fluorescent Derivatives of AC-42 To Probe Bitopic Orthosteric/Allosteric Binding Mechanisms on Muscarinic M1 Receptors
2012 · Sandrine B. Daval, Céline Valant, et al. · Journal of Medicinal Chemistry · 40
Works count: 114
Citation count: 3,614
H-index: 30
I10-index: 49
Year
Topic
Type